2008-09-05 - Male - 7 Years old
310833
| Adverse reaction report number | 310833 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2008-09-05 |
| Latest received date | 2008-09-05 |
| Age | 7 Years |
| Gender | Male |
| Weight | 60 Pounds |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | Community |
| Report outcome | Recovered/resolved |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | |
| Other medically important | Yes |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Unknown | 20 Milligram | 1 every 1 Day(s) | 7 Month(s) | Attention deficit/hyperactivity disorder |
| APO-GABAPENTIN | NOT SPECIFIED | Concomitant | |||||
| APO-SERTRALINE | CAPSULE | Concomitant | Unknown |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Aggression | |
| Drug ineffective | |